Sublicensing can be a tricky issue for all licensing professionals.  This 1 ½ hour online learning workshop provides insights for technology transfer and licensing professionals, enabling them to be better equipped to deal with sublicensing income returns, as relevant to different circumstances.

Most IP licenses include sublicensing provisions.  Over 60% of technology licenses are to small business (including start ups), which invariably sublicense at some stage down the development and commercialisation pipeline.  Missed revenue from unfortunate sublicensing income structuring  is common, which leads to missed opportunity and disputes.

This workshop reviews the major sublicensing income structures, as well as the benefits and pitfalls that arise in each circumstance.  Case studies are provided for context.

Don’t miss out on this webinar!  Seats are selling fast!

Course Date/Time
Tuesday 28 July 2020
11:00am – 12:30pm AEST

Fees
KCA Member: $100
Non-member: $150

REGISTER HERE

Workshop Facilitator: Dr Ashley Stevens, Focus IP Group, USA
Dr. Stevens joined the Office of Technology Development at Boston University in 1995. He has worked in the biotechnology industry for 28 years, assisting both start-up companies and academic organizations in turning promising ideas into useful products. Formerly, he served as director of the Office of Technology Transfer at the Dana-Farber Cancer Institute, a teaching affiliate of The Harvard Medical School. He was cofounder and general manager of Genmap, Inc., from which Myriad Genetics emerged, and was vice president of business development for BioTechnica International. He started his career with the Procter and Gamble Company, where he held positions in sales, marketing, strategic planning, and acquisitions. He frequently serves as an expert witness in intellectual property lawsuits. Dr. Stevens is a member of the Licensing Executives Society and is a past president of AUTM.